News | August 12, 2007

Less Than Half of Americans Fully Satisfied with Medical Care

August 13, 2007 — Only 48 percent of Americans age 18 and over who had gone to a doctor or medical clinic within a year of being surveyed rated their healthcare 9 or 10 on a scale in which 0 was the worst possible care and 10 the best, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

Patients' perceptions of quality varied by race, ethnicity, and type of insurance.

Only about a third of Asians (31 percent) and American Indians and Alaska Natives (37 percent) rated their care a 9 or 10, compared with less than half of whites (49 percent) and blacks (46 percent). Just 43 percent of Hispanics reported that they were receiving high quality healthcare.

Slightly less than 60 percent of people age 65 and older who have Medicare, with or without additional private or public health insurance, rated their care the highest, compared with 46 percent of privately insured patients and 39 percent of uninsured Americans.

Men and women rated were nearly equal in how they viewed the quality of their care, respectively, 46 percent and 49 percent saw their care as excellent.

This AHRQ News and Numbers is based on data from the 2006 National Healthcare Quality Report, which examines the quality of healthcare across America in four key areas - effectiveness of healthcare, patient safety, timeliness of care, and patient centeredness.

For more information: www.ahrq.gov

Related Content

Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their...
Some Pregnant Women Are Exposed to Gadolinium in Early Pregnancy
News | Women's Health | August 20, 2019
A small but concerning number of women are exposed to a commonly used magnetic resonance imaging (MRI) contrast agent...
New MRI Technique Captures Brain Changes in Near-real Time

Differences in stiffness between stimulus states. Image courtesy of Patz et al.

News | Neuro Imaging | August 19, 2019
An international team of researchers developed a new magnetic resonance imaging (MRI) technique that can capture an...
ADHD Medication May Affect Brain Development in Children

Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al.

News | Neuro Imaging | August 16, 2019
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation
Technology | Neuro Imaging | August 07, 2019
Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release...
Canon Medical Introduces Encore Orian MR Upgrade Program
News | Magnetic Resonance Imaging (MRI) | August 06, 2019
Canon Medical Systems USA Inc. is helping to provide low-cost patient care solutions for its customers with the launch...
FDA Issues Draft Guidance on Medical Device Safety in MRI Environment
News | Magnetic Resonance Imaging (MRI) | August 01, 2019 | Jeff Zagoudis, Associate Editor
The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n